Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEEL PCI: Ticagrelor vs clopidogrel in elective PCI
2014-004783-38Phase 4Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ticagrelor in coronary arteriosclerosis (3 arms), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Adenosine concentration in adenosine reuptake assay. Started Jan 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2014-004783-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004783-38.